Takeda Pharmaceutical Co Ltd 2023 Integrated Report
Company: Takeda Pharmaceutical Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2023
Type: Integrated Report
Pages: 60
The report highlights Takeda's expanded QDENGA dengue-vaccine approvals and its focus on equitable access to health care. It presents a Patient, People and Planet sustainability framework with corporate philosophy metrics, most of which were assured by KPMG. The company reports an accelerated net-zero goal for Scope 1 and 2 operations by 2035 and for its entire value chain, including estimated Scope 3 emissions, by 2040.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.